Interleukin-27 Gene Therapy Prevents the Development of Autoimmune Encephalomyelitis but Fails to Attenuate Established Inflammation due to the Expansion of CD11b(+)Gr-1(+) Myeloid Cells

Interleukin-27 (IL-27) and its subunit P28 (also known as IL-30) have been shown to inhibit autoimmunity and have been suggested as potential immunotherapeutic for autoimmune diseases such as multiple sclerosis (MS). However, the potential of IL-27 and IL-30 as immunotherapeutic, and their mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jianmin, Liu, Jin-Qing, Liu, Zhihao, Wu, Lisha, Shi, Min, Zhang, Jianchao, Davis, Jonathan P., Bai, Xue-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928207/
https://www.ncbi.nlm.nih.gov/pubmed/29740452
http://dx.doi.org/10.3389/fimmu.2018.00873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928207/
https://www.ncbi.nlm.nih.gov/pubmed/29740452
http://dx.doi.org/10.3389/fimmu.2018.00873

Ejemplares similares